CDKN2A and hepatocellular carcinoma: In addition, CDKN2A (Figure 8F, p = 2e-24), DLAT (Figure 8G, p = 8.8e-09), DLST(Figure 8H, p = 0.00047), GLS(Figure 8I, p = 2.5e-13) and PDHA1 (Figure 8J, p = 8.3e-14) were significantly different at the in HCC patients with high tumor grades, low tumor grades and adjacent normal tissues.